Literature DB >> 3686455

Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease.

G M Akoun1, C M Mayaud, J L Touboul, M F Denis, B J Milleron, J Y Perrot.   

Abstract

The results of bronchoalveolar lavage in three patients with a presumptive diagnosis of methotrexate induced lung disease are presented. Lavage fluid was characterised by the presence of large numbers of lymphocytes, which in two patients were predominantly lymphocytes of the T8 phenotype. These findings further support the hypothesis that immune mediated mechanisms may play a part in the pathogenesis of this disorder in some patients, and indicate that bronchoalveolar lavage may be helpful in the evaluation of patients suspected of having methotrexate induced lung disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686455      PMCID: PMC460901          DOI: 10.1136/thx.42.9.652

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Methotrexate-induced pneumonitis.

Authors:  H D Sostman; R A Matthay; C E Putman; G J Smith
Journal:  Medicine (Baltimore)       Date:  1976-09       Impact factor: 1.889

2.  Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.

Authors:  H Y Reynolds; H H Newball
Journal:  J Lab Clin Med       Date:  1974-10

3.  Pulmonary disease complicating intermittent therapy with methotrexate.

Authors:  A M Clarysse; W J Cathey; G E Cartwright; M M Wintrobe
Journal:  JAMA       Date:  1969-09-22       Impact factor: 56.272

4.  Drug-related pneumonitis and drug-induced hypersensitivity pneumonitis.

Authors:  G M Akoun; C M Mayaud; B J Milleron; P Y Perrot
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data.

Authors:  P H Gutin; M R Green; W A Bleyer; V L Bauer; P H Wiernik; M D Walker
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

6.  Bronchoalveolar lavage in gold lung.

Authors:  D B Ettensohn; N J Roberts; J J Condemi
Journal:  Chest       Date:  1984-04       Impact factor: 9.410

Review 7.  Drug-induced pulmonary disease. Part 1: Cytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-02

8.  Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.

Authors:  M G Kris; D Pablo; R J Gralla; M T Burke; J Prestifilippo; D Lewin
Journal:  Cancer Treat Rep       Date:  1984 Jul-Aug

9.  Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.

Authors:  D Luedke; T T McLaughlin; C Daughaday; S Luedke; B Harrison; G Reed; O Martello
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

  9 in total
  7 in total

Review 1.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Authors:  F Salaffi; P Manganelli; M Carotti; S Subiaco; G Lamanna; C Cervini
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

2.  Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis.

Authors:  A Schnabel; C Richter; S Bauerfeind; W L Gross
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

4.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

Review 5.  Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports.

Authors:  M R Hargreaves; A G Mowat; M K Benson
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

6.  Methotrexate-induced pericarditis and pericardial effusion; first reported case.

Authors:  L N Forbat; B W Hancock; A H Gershlick
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

Review 7.  Drug-Induced Interstitial Lung Disease: A Systematic Review.

Authors:  Sarah Skeoch; Nicholas Weatherley; Andrew J Swift; Alexander Oldroyd; Christopher Johns; Conal Hayton; Alessandro Giollo; James M Wild; John C Waterton; Maya Buch; Kim Linton; Ian N Bruce; Colm Leonard; Stephen Bianchi; Nazia Chaudhuri
Journal:  J Clin Med       Date:  2018-10-15       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.